DEC 03, 2020 8:30 AM PST

Oregon to Create Advisory Board for Psilocybin Mushroom Therapy

WRITTEN BY: Annie Lennon

Last month, Oregon became the first state in the US to legalize psilocybin mushrooms as a therapeutic treatment. Now, the state is recruiting for a 16-member Oregon psilocybin Therapy Board to design the requirements, specifications, and guidelines for psilocybin therapy in the state. 

The Oregon Health Authority (OHA) released the criteria for prospective members of the upcoming advisory board. There, they specify that physicians, psychologists, public health experts, scientific researchers, and representatives of state agencies, including OHA, may apply. They also invited those with experience in mycology, ethnobotany, psychopharmacology, and psilocybin harm reduction to apply, alongside members of the general public and representatives of Indian tribes. 

The OHA aims to establish the advisory board before January 2021, when they will begin the two-year process of specifying safety, practice, and training standards, alongside licensing specifications for facilitators, service centers, manufacturers, and testing laboratories. Following this process, they expect the therapy to be available in the first half of 2023. 

The creation of the board and criteria for its membership were stipulated under Measure 109, a bill that received the popular vote in Oregon in November. The bill also specified access to psilocybin-based therapy in a clinical context for adults over the age of 21 without any limitation on the type of condition to be treated. 

“We’re so pleased in the investment outlined in the Governor’s budget yesterday, which begins the important, two-year process to ensure that Oregon creates a safe, effective and equitable psilocybin therapy program,” said Sam Chapman, who was the Measure 109 campaign manager and will now work on implementing the program. 

“I look forward to working with the Governor, Legislature and the Oregon Health Authority in the months ahead to ensure a responsible implementation that prioritizes accessibility while maximizing safety."

 

Sources: Marijuana MomentYes 109Oregon.gov

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
APR 19, 2022
Health & Medicine
Pandemic Creates Opportunity to Study Rare Vaccine Side Effects
APR 19, 2022
Pandemic Creates Opportunity to Study Rare Vaccine Side Effects
The Global Vaccine Data Network (GVDN) is a project conceived over 10 years ago to study vaccine side effects. Back then ...
APR 28, 2022
Drug Discovery & Development
Keto Molecule Shows Promise for Treating Colorectal Cancer
APR 28, 2022
Keto Molecule Shows Promise for Treating Colorectal Cancer
A molecule produced when on low-carbohydrate ketogenic diets suppresses the growth of colorectal tumors in the lab. The ...
MAY 15, 2022
Drug Discovery & Development
Implanted Insulin-producing Cells for Diabetes Treatment
MAY 15, 2022
Implanted Insulin-producing Cells for Diabetes Treatment
Type 1 diabetes, which affects about 9 to 10 million people globally, occurs when the immune system incorrectly identifi ...
JUN 02, 2022
Cancer
Call to Diversify Clinical Trials
JUN 02, 2022
Call to Diversify Clinical Trials
Clinical Trials represent an integral component of biomedical research.  These research studies utilize human subje ...
JUN 10, 2022
Cannabis Sciences
Are Cannabis Users Nicer?
JUN 10, 2022
Are Cannabis Users Nicer?
A study published in Nature offers evidence that cannabis has a positive effect on the psychosocial health of young adul ...
JUN 27, 2022
Plants & Animals
Developing a New Approach to Rabies Vaccination
JUN 27, 2022
Developing a New Approach to Rabies Vaccination
Rabies is a viral disease that can spread through the saliva. Several kinds of animals can get rabies, including humans ...
Loading Comments...